NeoPharm CO., LTD. (092730.KQ)

KRW 11960.0

(-0.33%)

Net Debt Summary of NeoPharm CO., LTD.

  • NeoPharm CO., LTD.'s latest annual net debt in 2023 was -10.83 Billion KRW , down -3.28% from previous year.
  • NeoPharm CO., LTD.'s latest quarterly net debt in 2024 Q1 was -16.48 Billion KRW , down -52.13% from previous quarter.
  • NeoPharm CO., LTD. reported annual net debt of -10.48 Billion KRW in 2022, down -61.14% from previous year.
  • NeoPharm CO., LTD. reported annual net debt of -6.5 Billion KRW in 2021, up 5.64% from previous year.
  • NeoPharm CO., LTD. reported quarterly net debt of -16.48 Billion KRW for 2024 Q1, down -52.13% from previous quarter.
  • NeoPharm CO., LTD. reported quarterly net debt of -15.5 Billion KRW for 2023 Q1, down -47.84% from previous quarter.

Annual Net Debt Chart of NeoPharm CO., LTD. (2023 - 2012)

Historical Annual Net Debt of NeoPharm CO., LTD. (2023 - 2012)

Year Net Debt Net Debt Growth
2023 -10.83 Billion KRW -3.28%
2022 -10.48 Billion KRW -61.14%
2021 -6.5 Billion KRW 5.64%
2020 -6.89 Billion KRW -703.18%
2019 -858.91 Million KRW 89.29%
2018 -8.02 Billion KRW -91.88%
2017 -4.18 Billion KRW 44.67%
2016 -7.55 Billion KRW 5.12%
2015 -7.96 Billion KRW 0.0%
2012 -1.68 Billion KRW 0.0%

Peer Net Debt Comparison of NeoPharm CO., LTD.

Name Net Debt Net Debt Difference
Kolmar BNH Co., Ltd. 156.43 Billion KRW 106.925%